Clinical Trial Update: Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine combined with neurofeedback to modulate glutamatergic neurotransmission for alcohol use disorder. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Dr. med. Marcus Herdener | Conditions: Alcohol Abuse/Dependence, Alcohol Use Disorder (AUD) | Phase 2 | Status: RECRUITING